Stay updated on Optimal Pembrolizumab and Chemotherapy Sequence in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Optimal Pembrolizumab and Chemotherapy Sequence in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Optimal Pembrolizumab and Chemotherapy Sequence in NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The site update adds Revision: v3.5.0 and removes Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-21T20:14:32.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T12:51:59.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    The page displays a new revision tag: Revision: v3.4.2, replacing Revision: v3.4.1. This appears to be a metadata/version update rather than a substantive change to study content.
    Difference
    0.0%
    Check dated 2026-02-13T12:55:29.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Minor version update from v3.4.0 to v3.4.1; no substantive changes to study content or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T09:19:35.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    UI and metadata updates were applied: show/hide glossary options, capitalization adjustments (Last Update Submitted that Met QC Criteria, No FEAR Act data), and a new revision tag (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-22T17:34:38.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4 and the previous label removed. This appears to be a minor site update that does not affect the study details or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-01-15T10:38:00.000Z thumbnail image

Stay in the know with updates to Optimal Pembrolizumab and Chemotherapy Sequence in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Optimal Pembrolizumab and Chemotherapy Sequence in NSCLC Clinical Trial page.